BBB opening with focused ultrasound in nonhuman primates and Parkinson’s disease patients: Targeted AAV vector delivery and PET imaging DOI Creative Commons
Javier Blesa, José A. Pineda‐Pardo, Ken‐ichi Inoue

et al.

Science Advances, Journal Year: 2023, Volume and Issue: 9(16)

Published: April 19, 2023

Intracerebral vector delivery in nonhuman primates has been a major challenge. We report successful blood-brain barrier opening and focal of adeno-associated virus serotype 9 vectors into brain regions involved Parkinson’s disease using low-intensity focus ultrasound adult macaque monkeys. Openings were well tolerated with generally no associated abnormal magnetic resonance imaging signals. Neuronal green fluorescent protein expression was observed specifically confirmed opening. Similar openings safely demonstrated three patients disease. In these one monkey, followed by 18 F-Choline uptake the putamen midbrain based on positron emission tomography. This indicates cellular binding molecules that otherwise would not enter parenchyma. The less-invasive nature this methodology could facilitate viral for gene therapy might allow early repeated interventions to treat neurodegenerative disorders.

Language: Английский

Self-Healing Injectable Hydrogels for Tissue Regeneration DOI Creative Commons
Pascal Bertsch, Mani Diba, David Mooney

et al.

Chemical Reviews, Journal Year: 2022, Volume and Issue: 123(2), P. 834 - 873

Published: Aug. 5, 2022

Biomaterials with the ability to self-heal and recover their structural integrity offer many advantages for applications in biomedicine. The past decade has witnessed rapid emergence of a new class self-healing biomaterials commonly termed injectable, or printable context 3D printing. These injectable biomaterials, mostly hydrogels other soft condensed matter based on reversible chemistry, are able temporarily fluidize under shear stress subsequently original mechanical properties. Self-healing distinct compared traditional biomaterials. Most notably, they can be administered locally targeted minimally invasive manner through narrow syringe without need surgery. Their moldability allows patient-specific intervention shows great prospects personalized medicine. Injected facilitate tissue regeneration multiple ways owing viscoelastic diffusive nature, ranging from simple support, spatiotemporally controlled delivery cells therapeutics, local recruitment modulation host promote regeneration. Consequently, have been at forefront cutting-edge strategies. This study provides critical review current state As key challenges toward further maturation this exciting research field, we identify (i) trade-off between injectability vs physical stability, (ii) lack consensus rheological characterization quantitative benchmarks hydrogels, particularly regarding capillary flow syringes, (iii) practical limitations translation therapeutically effective formulations specific tissues. Hence, here chemical design strategies provide guide analysis, showcase applicability various tissues printing complex organoids.

Language: Английский

Citations

454

Evolution of drug delivery systems: From 1950 to 2020 and beyond DOI
Haesun Park, Andrew Otte, Kinam Park

et al.

Journal of Controlled Release, Journal Year: 2021, Volume and Issue: 342, P. 53 - 65

Published: Dec. 28, 2021

Language: Английский

Citations

280

Multifunctional nanoparticle-mediated combining therapy for human diseases DOI Creative Commons
Xiaotong Li,

Xiuju Peng,

Makhloufi Zoulikha

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2024, Volume and Issue: 9(1)

Published: Jan. 1, 2024

Abstract Combining existing drug therapy is essential in developing new therapeutic agents disease prevention and treatment. In preclinical investigations, combined effect of certain known drugs has been well established treating extensive human diseases. Attributed to synergistic effects by targeting various pathways advantages, such as reduced administration dose, decreased toxicity, alleviated resistance, combinatorial treatment now being pursued delivering combat major clinical illnesses, cancer, atherosclerosis, pulmonary hypertension, myocarditis, rheumatoid arthritis, inflammatory bowel disease, metabolic disorders neurodegenerative Combinatorial involves combining or co-delivering two more for a specific disease. Nanoparticle (NP)-mediated delivery systems, i.e., liposomal NPs, polymeric NPs nanocrystals, are great interest wide range due targeted delivery, extended release, higher stability avoid rapid clearance at infected areas. This review summarizes targets diseases, clinically approved combinations the development multifunctional emphasizes strategies based on severe Ultimately, we discuss challenging NP-codelivery translation provide potential approaches address limitations. offers comprehensive overview recent cutting-edge NP-mediated combination

Language: Английский

Citations

125

Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood–brain barrier (BBB) to manage neurological disorders DOI
Aline de Alcântara Correia, Ana Rita Monteiro,

RAYANNA BEATRIZ MARQUES DA SILVA

et al.

Advanced Drug Delivery Reviews, Journal Year: 2022, Volume and Issue: 189, P. 114485 - 114485

Published: Aug. 12, 2022

Language: Английский

Citations

103

Gold nanostructures: synthesis, properties, and neurological applications DOI
Iman Zare, Mohammad Tavakkoli Yaraki, G. Speranza

et al.

Chemical Society Reviews, Journal Year: 2022, Volume and Issue: 51(7), P. 2601 - 2680

Published: Jan. 1, 2022

Recent advances in nanotechnology are expected to increase our current understanding of neuroscience.

Language: Английский

Citations

82

Recent progresses in exosome-based systems for targeted drug delivery to the brain DOI
Santosh Bashyal,

Thapa Chhitij,

Sang Kil Lee

et al.

Journal of Controlled Release, Journal Year: 2022, Volume and Issue: 348, P. 723 - 744

Published: June 23, 2022

Language: Английский

Citations

82

Strategic Approaches to Improvise Peptide Drugs as Next Generation Therapeutics DOI Open Access
Panchali Barman, Shubhi Joshi, Sheetal Sharma

et al.

International Journal of Peptide Research and Therapeutics, Journal Year: 2023, Volume and Issue: 29(4)

Published: May 24, 2023

Language: Английский

Citations

63

Hyaluronic Acid‐Based Bioconjugate Systems, Scaffolds, and Their Therapeutic Potential DOI
Niranjan G. Kotla, Isma Liza Mohd Isa, Aitor Larrañaga

et al.

Advanced Healthcare Materials, Journal Year: 2023, Volume and Issue: 12(20)

Published: March 27, 2023

Abstract In recent years, the development of hyaluronic acid or hyaluronan (HA) based scaffolds, medical devices, bioconjugate systems have expanded into a broad range research and clinical applications. Research findings over last two decades suggest that abundance HA in most mammalian tissues with distinctive biological roles chemical simplicity for modifications made it an attractive material rapidly growing global market. Besides its use as native forms, has received much interest on so‐called “HA‐bioconjugates” “modified‐HA systems”. this review, importance HA, underlying rationale approaches, various advancements derivatives their potential physicochemical, pharmacological advantages are summarized. This review also highlights current emerging HA‐based conjugates small molecules, macromolecules, crosslinked systems, surface coating strategies implications, including potentials key challenges discussed detail.

Language: Английский

Citations

48

Opportunities and challenges in enhancing the bioavailability and bioactivity of dietary flavonoids: A novel delivery system perspective DOI

Dan Yuan,

Yujie Guo,

Feiyan Pu

et al.

Food Chemistry, Journal Year: 2023, Volume and Issue: 430, P. 137115 - 137115

Published: Aug. 7, 2023

Language: Английский

Citations

42

Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment DOI Creative Commons
Changhong Zhao,

Xinshu Zhu,

Jianmei Tan

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2024, Volume and Issue: 171, P. 116113 - 116113

Published: Jan. 5, 2024

Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor, characterized by high heterogeneity, strong invasiveness, poor prognosis, and a low survival rate. A broad range of nanoparticles have been recently developed as drug delivery systems for GBM therapy owing to their inherent size effect ability cross blood-brain barrier (BBB). Lipid-based (LBNPs), such liposomes, solid lipid NPs (SLNs), nano-structured carriers (NLCs), emerged promising system treatment because unique size, surface modification possibilities, proven bio-safety. In this review, main challenges current clinical strategies on how novel LBNPs overcome them were explored. The application progress LBNP-based in chemotherapy, immunotherapy, gene recent years systematically reviewed, prospect was discussed.

Language: Английский

Citations

30